Trial intelligence / Profile preview

Remimazolam for general anesthesia in elective surgery (Phase II)

CTR20150191Phase 2Completed

Sponsor
Hengrui Therapeutics
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of remimazolam, sponsored by Hengrui Therapeutics. Started Apr 2015; status: completed.

02

Drugs

remimazolam

Beyond the preview

Go deeper on CTR20150191.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150191.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call